Exact chief Conroy says Citron "dead wrong"


Unsurprisingly, Exact Sciences' CEO Kevin Conroy says short seller Citron Research is "dead wrong" in its bearish assessment of Cologuard. He commented on the issue in an interview on CNBC today.



from Biotech News